Keywords
GINS4
Proliferation
Tumor marker
Invasion
Submitted : 2024-05-05
Accepted : 2024-05-20
Published : 2024-06-04
Abstract
Objective: To analyze the role and influence of the GINS4 gene in breast cancer progression and to explore its expression in triple-negative and non-triple-negative breast cancer cell lines. Methods: Single-gene analysis of GINS4 was performed by breast cancer RNA transcriptome data from The Cancer Genome Atlas (TCGA). Real-time quantitative polymerase chain reaction (PCR) was used to detect the expression of GINS4 in triple-negative and non-triple-negative breast cancer cell lines. The knockdown effects of GINS4 in MDA-MB-231 and MCF-7 cell lines on the proliferation and invasion of breast cancer cells were examined by cell counting kit 8 (CCK8) and Transwell assays. Results: Bioinformatics analysis showed that the expression of GINS4 in breast cancer was significantly higher than that in normal breast tissues (P > 0.05). At the same time, cell experiments confirmed that GINS4 was highly expressed in human breast cancer cell lines with normal breast cells as reference and in MDA-MB-231 and MCF-7 cell lines as reference, where the ability of proliferation and invasion of MDA-MB-231 and MCF-7 cells decreased after GINS4 knockdown. Conclusion: GINS4 is a gene associated with breast cancer malignancy, which can act as a novel tumor marker and has the potential as a new therapeutic target for breast cancer.
References
Britt KL, Cuzick J, Phillips KA, 2020, Key Steps for Effective Breast Cancer Prevention. Nat Rev Cancer, 20(8): 417–436.
Kong L, Ueno M, Itoh M, et al., 2006, Identification and Characterization of Mouse PSF1-Binding Protein, SLD5. Biochem Biophys Res Commun, 339(4): 1204–1207.
Matheson CJ, Backos DS, Reigan P, 2016, Targeting WEE1 Kinase in Cancer. Trends Pharmacol Sci, 37(10): 872–881.
Joshi K, Shah VJ, Maddika S, 2016, GINS Complex Protein SLD5 Recruits SIK1 to Activate MCM Helicase During DNA Replication. Cellular Signaling, 28(12): 1852–1862.
Ilves I, Petojevic T, Pesavento JJ, et al., 2010, Activation of the MCM2-7 Helicase by Association with CDC45 and GINS Proteins. Molecular cell, 37(2): 247–258.
Kamada K, Kubota Y, Arata T, et al., 2007, Structure of the Human GINS Complex and its Assembly and Functional Interface in Replication Initiation. Nat Struct Mol Biol, 2007, 14(5): 388–396.
Labib K, Gambus A, 2007, A Key Role for The GINS Complex at DNA Replication Forks. Trends Cell Biol, 17(6): 271–278.
Chen L, Cai Q, Yang R, et al., 2023, GINS4 Suppresses Ferroptosis by Antagonizing p53 Acetylation with Snail. Proceedings of the National Academy of Sciences of the United States of America, 120(15): e2219585120.
Li H, Cao Y, Ma J, et al., 2021, Expression and Prognosis Analysis of GINS Subunits in Human Breast Cancer. Medicine (Baltimore), 100(11): e24827.
Wang L, Zhang S, Wang X, 2020, The Metabolic Mechanisms of Breast Cancer Metastasis. Frontiers in Oncology, 10: e602416.
The Cancer Genome Atlas Network, 2012, Comprehensive Molecular Portraits of Human Breast Tumors. Nature, 490(7418): 61–70.
Lian YF, Li SS, Huang YL, et al., 2018, Up-Regulated and Interrelated Expressions of GINS Subunits Predict Poor Prognosis in Hepatocellular Carcinoma. Biosci Rep, 38(6): BSR20181178.
Rong Z, Luo Z, Zhang J, et al., 2020, GINS Complex Subunit 4, A Prognostic Biomarker and Reversely Mediated by Krüppel-Like Factor 4, Promotes the Growth of Colorectal Cancer. Cancer Sci, 111(4): 1203–1217.
Zhang K, Zhou J, Wu T, et al., 2022, Combined Analysis of Expression, Prognosis and Immune Infiltration of GINS Family Genes in Human Sarcoma. Aging (Albany NY), 14(14): 5895–5907.
Zhu Z, Yu Z, Rong Z, et al., 2019, The Novel GINS4 Axis Promotes Gastric Cancer Growth and Progression by Activating Rac1 and CDC42. Theranostics, 9(26): 8294–8311.
Liu B, Liu Z, Wang Y, et al., 2021, Overexpression of GINS4 is Associated with Poor Prognosis and Survival in Glioma Patients. Mol Med, 27(117).
Jin D, Yuan L, Li F, et al., 2022, GINS4 Might Be a Novel Prognostic Immune-Related Biomarker of Not Only Esophageal Squamous Cell Carcinoma and Other Cancers. BMC Medical Genomics, 15(1): 75.
Li H, Zhou Q, Wu Z, et al., 2023, Identification of Novel Key Genes Associated with Uterine Corpus Endometrial Carcinoma Progression and Prognosis. Annals of Translational Medicine, 11(2): 100.
Chen L, Cai Q, Yang R, et al., 2023, GINS4 Suppresses Ferroptosis by Antagonizing p53 Acetylation with Snail. Proc Natl Acad Sci USA, 120(15): e2219585120.
Sun L, Chen S, Wang T, et al., 2023, Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis. Clin Breast Cancer, 23(3): 281–290.
Sagredo EA, Blanco A, Sagredo AI, et al., 2018, ADAR1-Mediated RNA-Editing of 3’UTRs in Breast Cancer. Biol Res, 51(1): 36.